Pfizer’s Rathbun “seconded” To SAFE-BioPharma
Executive Summary
George Rathbun will continue as Pfizer's global research development informatics director as he assumes the additional position of SAFE-BioPharma Association chief technology officer. "Pfizer has seconded Rathbun to SAFE-BioPharma," the industry-sponsored organization says in a Nov. 17 release. Rathbun, who will take over the new position immediately, will oversee and manage all aspects of technology for the organization, which is responsible for developing and managing secure digital signature standards (1"The Pink Sheet" July 11, 2005, p. 25)...
You may also be interested in...
Rx Industry E-Signature Standard Will Be Used In NCI Clinical Trials In 2006
A digital signature standard developed by the pharmaceutical industry will be ready for use in National Cancer Institute studies by 2006
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.